Provided by Tiger Trade Technology Pte. Ltd.

Regenxbio

9.45
-0.2100-2.17%
Volume:597.29K
Turnover:5.59M
Market Cap:623.82M
PE:-2.51
High:9.68
Open:9.50
Low:9.09
Close:9.66
52wk High:16.19
52wk Low:5.46
Shares:66.01M
Float Shares:57.34M
Volume Ratio:0.33
T/O Rate:1.04%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.7652
EPS(LYR):-3.7593
ROE:-137.63%
ROA:-21.20%
PB:8.69
PE(LYR):-2.51

Loading ...

Regenxbio - Does not Expect to Resubmit Rgx-121 Bla in Near Term

THOMSON REUTERS
·
Aug 24

NASDAQ Trade Halt Halt News Pending at 07:00 Am

Reuters
·
Aug 24

Trump Picks White House Adviser Heidi Overton to Run FDA, Source Says

Reuters
·
Aug 19

Regenxbio Price Target Cut to $23.00/Share from $26.00 by HC Wainwright & Co.

Dow Jones
·
Aug 10

Regenxbio price target lowered to $23 from $26 at H.C. Wainwright

TIPRANKS
·
Aug 10

Regenxbio Seen on Track for Duchenne Approval as Data Strengthens, RBC Says

MT Newswires Live
·
Aug 08

Regenxbio Cut to Equal-Weight from Overweight by Barclays

Dow Jones
·
Aug 07

Morgan Stanley Adjusts Price Target on REGENXBIO to $18 From $16, Maintains Overweight Rating

MT Newswires Live
·
Aug 07

Regenxbio downgraded to Equal Weight from Overweight at Barclays

TIPRANKS
·
Aug 07

RegenXBio (RGNX) was downgraded to a Hold Rating at Barclays

TIPRANKS
·
Aug 07

Solid Biosciences Q2 Net Loss Widens on Higher R&D Costs

Reuters
·
Aug 07

Verastem Q2 Revenue Jumps on New Product Sales and Milestone

Reuters
·
Aug 07

Regenxbio Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 06

Regenxbio Q2 Revenue Surges on AbbVie Milestone Payment

Reuters
·
Aug 06

Regenxbio Q2 FY26 Swings to Net Income of $22.71 Million; Revenue Climbs to $108.02 Million

Reuters
·
Aug 06

Regenxbio Q2 EPS $0.43 Beats $(0.03) Estimate, Sales $108.019M Miss $117.127M Estimate

Benzinga Earnings
·
Aug 06

Regenxbio Q2 Operating Expenses USD 78.756 Million

Reuters
·
Aug 06

Regenxbio Q2 License & Royalty Revenue USD 103.841 Million

THOMSON REUTERS
·
Aug 06

Regenxbio Inc Expected to Post Earnings of 6 Cents a Share - Earnings Preview

Reuters
·
Aug 03

Regenxbio Schedules Conference Call to Discuss Second-Quarter Results and Operational Update

Reuters
·
Aug 03